A Novel In Vivo Model to Simultaneously Assess Efficacy and Toxicity of Chimeric Antigen Receptor T-Cell Immunotherapy Published Date October 4, 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen